共 50 条
Serial Bronchoalveolar Lavage Fluid Aspergillus Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis
被引:2
|作者:
Friedman, Daniel Z. P.
[1
,2
,7
]
Theel, Elitza S.
[3
]
Walker, Randall C.
[1
]
Vikram, Holenarasipur R.
[4
]
Razonable, Raymund R.
[1
,5
]
Vergidis, Paschalis
[1
,5
,6
]
机构:
[1] Mayo Clin, Sect Infect Dis, Dept Med, Rochester, MN USA
[2] Univ Chicago, Sect Infect Dis & Publ Hlth, Chicago, IL USA
[3] Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN USA
[4] Mayo Clin, Div Infect Dis, Phoenix, AZ USA
[5] Mayo Clin, William J von Liebig Ctr Transplantat & Clin Regen, Rochester, MN USA
[6] Mayo Clin, 200 First St SW, Rochester, MN 55905 USA
[7] Univ Chicago, 5841 S Maryland Ave, Chicago, IL 60637 USA
来源:
OPEN FORUM INFECTIOUS DISEASES
|
2024年
/
11卷
/
04期
关键词:
aspergillosis;
bronchoscopy;
galactomannan;
hematopoietic stem cell transplant;
solid organ transplant;
DIAGNOSIS;
D O I:
10.1093/ofid/ofae114
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
We studied patients diagnosed with aspergillosis based on positive bronchoalveolar lavage (BAL) Aspergillus galactomannan (GM) who had follow-up BAL sampling within 180 days. GM trend and clinical outcome were concordant in only 60% (30/50). While useful for the initial diagnosis, BAL GM trending does not always correlate with treatment response.
引用
收藏
页数:4
相关论文